US 11078250
High-activity long-acting hypoglycemic fusion protein as well as preparation method and medical application thereof
granted A61KA61K38/22A61P
Quick answer
US patent 11078250 (High-activity long-acting hypoglycemic fusion protein as well as preparation method and medical application thereof) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHINA PHARMACEUTICAL UNIVERSITY
- Grant date
- Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/22, A61P, A61P3/08